Arcadia Biosciences, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Salameh Roger | VP Business Development | Sale | 1,648 | $4.92 | $8,108 | 18,012 | Sep 11, 2015 |
| Lu Zhongjin | VP Product Development | Sale | 1,068 | $4.92 | $5,255 | 14,760 | Sep 11, 2015 |
| Knauf Vic C. | Chief Scientific Officer | Sale | 575 | $5.27 | $3,030 | 31,661 | Sep 9, 2015 |
| Wong Mark | — | Option Exercise | 5,000 | $0.44 | $2,200 | 5,000 | Sep 9, 2015 |
| Reis James Richard | — | Option Exercise | 10,000 | $1.08 | $10,800 | 30,000 | Sep 9, 2015 |
| Salameh Roger | VP Business Development | Option Exercise | 8,115 | $0.44 | $3,571 | 14,949 | Sep 8, 2015 |
| Lu Zhongjin | VP Product Development | Option Exercise | 3,685 | $0.44 | $1,621 | 14,172 | Sep 8, 2015 |
| Garg Uday | — | Purchase | 375,000 | $8.00 | $3,000,000 | 375,000 | May 20, 2015 |
| Gujadhur Tej | — | C | 8,705,808 | — | — | 8,705,808 | May 20, 2015 |
| Redfern Dominic | — | C | 8,705,808 | — | — | 8,705,808 | May 20, 2015 |
| Garg Uday | — | Purchase | 375,000 | $8.00 | $3,000,000 | 375,000 | May 20, 2015 |
| Shupp Darby E | — | C | 3,847,751 | — | — | 20,178,916 | May 20, 2015 |
| Reis James Richard | — | Purchase | 12,500 | $8.00 | $100,000 | 12,500 | May 20, 2015 |
| Knauf Vic C. | Chief Scientific Officer | C | 7,812 | — | — | 7,812 | May 20, 2015 |
| John G. Sperling 2012 Irrevocable Trust No. 3 | — | C | 3,847,751 | — | — | 20,178,916 | May 20, 2015 |